| Reference |
|---|
Kitadai E, Yamaguchi K, Ohshimo S, Iwamoto H, Sakamoto S, Horimasu Y, et al. Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study. Respir Res. 2024;25:405 pubmed publisher |
Charoenvicha C, Thongsroy J, Apaijai N, Attachaipanich T, Sirimaharaj W, Khwanngern K, et al. Alterations of senescence-associated markers in patients with non-syndromic cleft lip and palate. Sci Rep. 2024;14:22555 pubmed publisher |
Ye D, Miyoshi A, Ushitani T, Kadoya M, Igeta M, Konishi K, et al. RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation. Brain Behav Immun. 2024;116:329-348 pubmed publisher |
Perkins R, Miranda E, Varshney P, Farabi S, Quinn L, Haus J. Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal- and abnormal-glucose-tolerant individuals. Physiol Rep. 2023;11:e15859 pubmed publisher |
Meza Fuentes G, L xf3 pez R, Vial C, Cortés L, Retamal M, Delgado I, et al. Assessing Pulmonary Epithelial Damage in Hantavirus Cardiopulmonary Syndrome: Challenging the Predominant Role of Vascular Endothelium through sRAGE as a Potential Biomarker. Viruses. 2023;15: pubmed publisher |
Schr xf6 der L, Rupp A, Gihr K, Kobilay M, Domroese C, Mallmann M, et al. Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies. Cancers (Basel). 2023;15: pubmed publisher |
Elsadek M. Effectiveness of two photosensitizer-mediated photodynamic therapy for treating moderate peri-implant infections in type-II diabetes mellitus patients: A randomized clinical trial. Photodiagnosis Photodyn Ther. 2023;43:103643 pubmed publisher |
Barnard S, Haunschild J, Heiser L, Dieterlen M, Klaeske K, Borger M, et al. Apoptotic Cell Death in Bicuspid-Aortic-Valve-Associated Aortopathy. Int J Mol Sci. 2023;24: pubmed publisher |
Peng Y, Liu F, Qiao Y, Wang P, Du H, Si C, et al. Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer. Cancers (Basel). 2022;14: pubmed publisher |
Butcher L, Zaldua J, Carnicero J, Hawkins K, Whitley J, Mothukuri R, et al. High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone. Respir Res. 2022;23:303 pubmed publisher |
Reichert S, Hofmann B, Kohnert M, Santos A, Friebe L, Grollmitz J, et al. Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG). J Clin Med. 2022;11: pubmed publisher |
Galliera E, Massaccesi L, Yu L, He J, Ranucci M, Corsi Romanelli M. SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome. Biomolecules. 2022;12: pubmed publisher |
Karas A, Holmannová D, Borsky P, Fiala Z, Andrys C, Hamakova K, et al. Significantly Altered Serum Levels of NAD, AGE, RAGE, CRP, and Elastin as Potential Biomarkers of Psoriasis and Aging-A Case-Control Study. Biomedicines. 2022;10: pubmed publisher |
Helou C, Nogueira Silva Lima M, Niquet Leridon C, Jacolot P, Boulanger E, Delguste F, et al. Plasma Levels of Free NƐ-Carboxymethyllysine (CML) after Different Oral Doses of CML in Rats and after the Intake of Different Breakfasts in Humans: Postprandial Plasma Level of sRAGE in Humans. Nutrients. 2022;14: pubmed publisher |
Wick K, Siegel L, Neaton J, Oldmixon C, Lundgren J, Dewar R, et al. RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19. JCI Insight. 2022;7: pubmed publisher |
Sin S, Lim M, Kim J, Bak S, Kim W. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene. BMC Pulm Med. 2022;22:58 pubmed publisher |
Drosatos I, Tsoporis J, Izhar S, Gupta S, Tsirebolos G, Sakadakis E, et al. Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits. Biomolecules. 2021;11: pubmed publisher |
Diekmann F, Chouvarine P, Sallmon H, Meyer Kobbe L, Kieslich M, Plouffe B, et al. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension. Int J Mol Sci. 2021;22: pubmed publisher |
Ene C, Georgescu S, Tampa M, Matei C, Mitran C, Mitran M, et al. Cellular Response against Oxidative Stress, a Novel Insight into Lupus Nephritis Pathogenesis. J Pers Med. 2021;11: pubmed publisher |
Lazzari T, Cavalheiro E, Coutinho S, da Silva L, Silva D. Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients. PLoS ONE. 2021;16:e0254198 pubmed publisher |
Gutmann C, Takov K, Burnap S, Singh B, Ali H, Theofilatos K, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021;12:3406 pubmed publisher |
Jabaudon M, Pereira B, Laroche E, Roszyk L, Blondonnet R, Audard J, et al. Changes in Plasma Soluble Receptor for Advanced Glycation End-Products Are Associated with Survival in Patients with Acute Respiratory Distress Syndrome. J Clin Med. 2021;10: pubmed publisher |
Ene C, Penescu M, Georgescu S, Tampa M, Nicolae I. Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma. Metabolites. 2020;11: pubmed publisher |
Zhou X, Lin N, Zhang M, Wang X, An Y, Su Q, et al. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer. BMC Endocr Disord. 2020;20:170 pubmed publisher |
C R, Lukose B, Rani P. G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology. PLoS ONE. 2020;15:e0225487 pubmed publisher |
Swami P, Thiyagarajan S, Vidger A, Indurthi V, Vetter S, Leclerc E. RAGE Up-Regulation Differently Affects Cell Proliferation and Migration in Pancreatic Cancer Cells. Int J Mol Sci. 2020;21: pubmed publisher |
Korça E, Piskovatska V, Borgermann J, Navarrete Santos A, Simm A. Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis. Sci Rep. 2020;10:17105 pubmed publisher |
Bourron O, Phan F, Diallo M, Hajage D, Aubert C, Carlier A, et al. Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study. Cardiovasc Diabetol. 2020;19:140 pubmed publisher |
Vinton C, Starke C, Ortiz A, Lai S, Flynn J, Sortino O, et al. Biomarkers of Cellular Stress Do Not Associate with sCD14 in Progressive HIV and SIV Infections in Vivo. Pathog Immun. 2020;5:68-88 pubmed publisher |
Holte K, Svanteson M, Hanssen K, Sveen K, Seljeflot I, Solheim S, et al. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study. PLoS ONE. 2020;15:e0233174 pubmed publisher |
Ebert H, Lacruz M, Kluttig A, Simm A, Greiser K, Tiller D, et al. Association between advanced glycation end products, their soluble receptor, and mortality in the general population: Results from the CARLA study. Exp Gerontol. 2020;131:110815 pubmed publisher |
Kumar N, Moideen K, Nancy A, Viswanathan V, Shruthi B, Sivakumar S, et al. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy. BMC Infect Dis. 2019;19:1039 pubmed publisher |
Scurt F, Menne J, Brandt S, Bernhardt A, Mertens P, Haller H, et al. Systemic Inflammation Precedes Microalbuminuria in Diabetes. Kidney Int Rep. 2019;4:1373-1386 pubmed publisher |
Ebert H, Lacruz M, Kluttig A, Simm A, Greiser K, Tiller D, et al. Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort. BMC Geriatr. 2019;19:299 pubmed publisher |
Gelžinský J, Mayer O, Seidlerova J, Mateřánková M, Mareš Š, Kordíková V, et al. Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness. Hypertens Res. 2020;43:111-120 pubmed publisher |
Mendoza Núñez V, García Martínez B, Rosado Pérez J, Santiago Osorio E, Pedraza Chaverri J, Hernandez Abad V. The Effect of 600 mg Alpha-lipoic Acid Supplementation on Oxidative Stress, Inflammation, and RAGE in Older Adults with Type 2 Diabetes Mellitus. Oxid Med Cell Longev. 2019;2019:3276958 pubmed publisher |
Ruelas Cinco E, Ru xed z Madrigal B, Dom xed nguez Rosales J, Maldonado Gonz xe1 lez M, De la Cruz Color L, Ram xed rez Meza S, et al. Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin resistance. Iran J Basic Med Sci. 2019;22:623-630 pubmed publisher |
Abdulle A, Inman C, Saleh A, Noshi M, Galani D, AbdelWareth L, et al. Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs. J Clin Transl Endocrinol. 2019;16:100192 pubmed publisher |
da Silva L, Skupien E, Lazzari T, Holler S, de Almeida E, Zampieri L, et al. Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status. PLoS ONE. 2019;14:e0213991 pubmed publisher |
Popp C, St Jules D, Hu L, Ganguzza L, Illiano P, Curran M, et al. The rationale and design of the personal diet study, a randomized clinical trial evaluating a personalized approach to weight loss in individuals with pre-diabetes and early-stage type 2 diabetes. Contemp Clin Trials. 2019;79:80-88 pubmed publisher |
Maresca A, Guasti L, Bozzini S, Mongiardi C, Tandurella N, Corso R, et al. sRAGE and early signs of cardiac target organ damage in mild hypertensives. Cardiovasc Diabetol. 2019;18:17 pubmed publisher |
Chiang K, Chen J, Huang S, Leu H, Lin S, Huang P. The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients. BMC Endocr Disord. 2018;18:84 pubmed publisher |
Machahua C, Montes Worboys A, Planas Cerezales L, Buendia Flores R, Molina Molina M, Vicens Zygmunt V. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis. Respir Res. 2018;19:215 pubmed publisher |
Klont F, Joosten M, ten Hacken N, Horvatovich P, Bischoff R. Quantification of the soluble Receptor of Advanced Glycation End-Products (sRAGE) by LC-MS after enrichment by strong cation exchange (SCX) solid-phase extraction (SPE) at the protein level. Anal Chim Acta. 2018;1043:45-51 pubmed publisher |
White D, Hoogeveen R, Chen L, Richardson P, Ravishankar M, Shah P, et al. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med. 2018;7:2180-2191 pubmed publisher |
Jabaudon M, Berthelin P, Pranal T, Roszyk L, Godet T, Faure J, et al. Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study. Sci Rep. 2018;8:2603 pubmed publisher |
Zhu W, Kim B, Wang M, Huang J, Isak A, Bexiga N, et al. TGFβ1 reinforces arterial aging in the vascular smooth muscle cell through a long-range regulation of the cytoskeletal stiffness. Sci Rep. 2018;8:2668 pubmed publisher |
Srinivasan L, Kilpatrick L, Shah S, Abbasi S, HARRIS M. Elevations of novel cytokines in bacterial meningitis in infants. PLoS ONE. 2018;13:e0181449 pubmed publisher |
Paradela Dobarro B, Fernández Trasancos Á, Bou Teen D, Eiras S, González Ferreiro R, Agra R, et al. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition. Cardiovasc Diabetol. 2017;16:115 pubmed publisher |
Negrin L, Halat G, Kettner S, Gregori M, Ristl R, Hajdu S, et al. Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of pulmonary complications in polytraumatized patients with severe chest trauma. PLoS ONE. 2017;12:e0175303 pubmed publisher |
Tasca K, Caleffi J, Correa C, Gatto M, de Camargo C, Mendes M, et al. The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals. Mediators Inflamm. 2016;2016:2909576 pubmed publisher |
Wang B, Li J, Yang Q, Zhang F, Hao M, Guo Y. Decreased levels of sRAGE in follicular fluid from patients with PCOS. Reproduction. 2017;153:285-292 pubmed publisher |
Boraldi F, Bartolomeo A, De Biasi S, Orlando S, Costa S, Cossarizza A, et al. Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction. PLoS ONE. 2016;11:e0160153 pubmed publisher |
Heier M, Margeirsdottir H, Gaarder M, Stensæth K, Brunborg C, Torjesen P, et al. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study. Cardiovasc Diabetol. 2015;14:126 pubmed publisher |
Lee A, Lam J, Shiu S, Wong Y, Betteridge D, Tan K. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes. PLoS ONE. 2015;10:e0137330 pubmed publisher |
Jabaudon M, Blondonnet R, Roszyk L, Pereira B, Guérin R, Perbet S, et al. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study. PLoS ONE. 2015;10:e0135857 pubmed publisher |
Chou C, Lin F, Tsai H, Chang S. The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia. BMC Pulm Med. 2014;14:182 pubmed publisher |
Moser B, Megerle A, Bekos C, Janik S, Szerafin T, Birner P, et al. Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH. PLoS ONE. 2014;9:e106440 pubmed publisher |
Momma H, Niu K, Kobayashi Y, Huang C, Chujo M, Otomo A, et al. Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study. Diabetol Metab Syndr. 2014;6:33 pubmed publisher |
Wei W, Kim J, Medina D, Lakatta E, Lin L. GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells. Protein Expr Purif. 2014;95:143-8 pubmed publisher |
Zakiyanov O, Kříha V, Vachek J, Zima T, Tesar V, Kalousova M. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box. BMC Nephrol. 2013;14:245 pubmed publisher |
Campbell D, Somaratne J, Jenkins A, Prior D, Yii M, Kenny J, et al. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS ONE. 2012;7:e49813 pubmed publisher |
Brix J, Höllerl F, Kopp H, Schernthaner G, Schernthaner G. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity. Int J Obes (Lond). 2012;36:1412-7 pubmed publisher |
Wittwer C, Lehner J, Fersching D, Siegele B, Stoetzer O, Holdenrieder S. Methodological and preanalytical evaluation of a RAGE immunoassay. Anticancer Res. 2012;32:2075-8 pubmed |
Narvaez Rivera R, Rendon A, Salinas Carmona M, Rosas Taraco A. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis. BMC Infect Dis. 2012;12:15 pubmed publisher |
Colhoun H, Betteridge D, Durrington P, Hitman G, Neil A, Livingstone S, et al. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Diabetes. 2011;60:2379-85 pubmed publisher |
Yamakawa N, Uchida T, Matthay M, Makita K. Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2011;300:L516-25 pubmed publisher |
Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med. 2011;39:480-8 pubmed publisher |
Nin J, Jorsal A, Ferreira I, Schalkwijk C, Prins M, Parving H, et al. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes. 2010;59:2027-32 pubmed publisher |
Penfold S, Coughlan M, Patel S, Srivastava P, Sourris K, Steer D, et al. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int. 2010;78:287-95 pubmed publisher |
Tam H, Shiu S, Wong Y, Chow W, Betteridge D, Tan K. Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes. Atherosclerosis. 2010;209:173-7 pubmed publisher |
Bastarache J, Fremont R, Kropski J, Bossert F, Ware L. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1035-41 pubmed publisher |
Buhimschi C, Baumbusch M, Dulay A, Oliver E, Lee S, Zhao G, et al. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol. 2009;175:958-75 pubmed publisher |
Mahajan N, Malik N, Bahl A, Dhawan V. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis. 2009;207:597-602 pubmed publisher |
Makam M, Diaz D, Laval J, Gernez Y, Conrad C, Dunn C, et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A. 2009;106:5779-83 pubmed publisher |
Yan X, Lu L, Peng W, Wang L, Zhang Q, Zhang R, et al. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis. 2009;205:544-8 pubmed publisher |
Iłzecka J. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2009;120:119-22 pubmed publisher |
Katakami N, Matsuhisa M, Kaneto H, Matsuoka T, Sakamoto K, Yasuda T, et al. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Atherosclerosis. 2009;204:288-92 pubmed publisher |
Hållström L, Berghäll E, Frostell C, Sollevi A, Soop A. Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia. Crit Care Med. 2008;36:3043-7 pubmed publisher |
Calfee C, Ware L, Eisner M, Parsons P, Thompson B, Wickersham N, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008;63:1083-9 pubmed publisher |
Rosas I, Richards T, Konishi K, Zhang Y, Gibson K, Lokshin A, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008;5:e93 pubmed publisher |
Gross S, van Ree R, Oterdoom L, de Vries A, van Son W, de Jong P, et al. Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients. Transplantation. 2007;84:659-63 pubmed |
